Source link : https://newshealth.biz/health-news/complement-inhibitor-slowed-kidney-decline-in-iga-nephropathy/
Iptacopan significantly slowed kidney function decline over 24 months compared with placebo in adults with IgA nephropathy. The complement inhibitor was granted accelerated approved in 2024; continued approval was contingent on demonstrating slowed kidney decline. Fewer participants in the iptacopan group reached the composite kidney-failure endpoint. Iptacopan (Fabhalta) slowed kidney function decline in adults with […]
The post Complement Inhibitor Slowed Kidney Decline in IgA Nephropathy first appeared on News Health.
—-
Author : News Health
Publish date : 2026-03-29 05:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8